Optos
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | 97.0m | 93.3m | 112m | 107m | 114m | - | - |
% growth | (11 %) | (4 %) | 20 % | (4 %) | 6 % | - | - |
EBITDA | 30.9m | 33.0m | 44.6m | 30.4m | 40.0m | 44.8m | 49.6m |
% EBITDA margin | 32 % | 35 % | 40 % | 28 % | 35 % | - | - |
Profit | 23.3m | 24.6m | 34.2m | 19.7m | 26.5m | - | - |
% profit margin | 24 % | 26 % | 31 % | 18 % | 23 % | - | - |
R&D budget | 4.1m | 60.0m | 7.1m | 8.6m | 8.9m | - | - |
R&D % of revenue | 4 % | 64 % | 6 % | 8 % | 8 % | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | IPO | |
$400m Valuation: $400m 25.7x EV/LTM EBITDA | Acquisition | ||
N/A | Grant | ||
Total Funding | - |
Recent News about Optos
EditOptos is a company specializing in advanced retinal imaging systems designed to capture ultra widefield (UWF) images of the retina. Founded in 1990 by Douglas Anderson, the company was inspired by a personal experience when Anderson's son suffered a spontaneous retinal detachment. Optos serves a diverse range of clients including independent High Street optometrists, eye clinics at renowned institutions like Great Ormond Street Hospital in London and Harvard Medical Center in Massachusetts. The company operates in the medical imaging market, focusing on eye care diagnostics. Its business model revolves around the sale and service of its imaging devices, generating revenue through both direct sales and service programs tailored to customer needs. Optos' systems are designed to speed up eye examinations, allowing practitioners to spend more quality time with patients, thereby enhancing customer satisfaction and increasing the likelihood of positive word-of-mouth referrals.
Keywords: retinal imaging, ultra widefield, eye care, diagnostics, optometrists, clinics, medical imaging, patient satisfaction, service programs, healthcare technology.